http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f715e976f4741c048fff82013abfd7d8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Yellin |
| name | Michael Yellin |
| given-name | Michael |
| organization-name | From Columbia University, College of Physicians and Surgeons, New York, NY (C.Y.W., S.P.M., K.M., S.T., S.H., M.Y., L.C., A.F., M.C.O., D.J.P.), and Biogen Inc, Cambridge, Mass (S.L.K.). From the University of Southern California/Norris Comprehensive Cancer Center; The Angeles Clinic and Research Institute, Los Angeles, CA; Robert Franz Cancer Center, Earle A. Chiles Research Institute, Portland, OR; the University of Arizona Cancer Center, Tucson, AZ; Carolina Bio-Oncology Institute, Huntersville, NC; and Medarex, Inc, Annadale, NJ From the Departments of Medicine, Urology, and Preventive Medicine, Keck/University of Southern California School of Medicine, Los Angeles; Department of Medicine, Stanford University School of Medicine, Stanford, CA; and Medarex Inc, Bloomsbury, NJ Celldex Therapeutics Inc., Hampton, NJ 08827, USA. Authors' Affiliations: Departments of 1Cutaneous Oncology and 2Biostatistics, Moffitt Cancer Center, Tampa, Florida; Departments of 3Medicine and 4Preventive Medicine, Keck/USC School of Medicine, Los Angeles, California, 5Cedars-Sinai Medical Center, Los Angeles, California; and 6Medarex, Inc, Annandale, New Jersey From the Mayo Clinic School of Medicine, Rochester, MN; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Cologne, Cologne, Germany; American Health Network Oncology, Indianapolis, IN; Ohio State University, Columbus, OH; University of Medicine and Dentistry of New Jersey, Newark; and Medarex Inc, Princeton, NJ 3Medarex, Inc., Princeton, New Jersey From the Surgery Branch and Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Medarex Inc, Princeton NJ |
Incoming Links
Showing number of triples: 1 to 27 of 27.